ENvue Medical Inc
FEED
13 hedge funds and large institutions have $679K invested in ENvue Medical Inc in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
18% more funds holding
Funds holding: 11 → 13 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less capital invested
Capital invested by funds: $906K → $679K (-$227K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$53.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$1.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$56.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $299K | – | – | – |
|
|
AFS
2
Amtrust Financial Services
New York
| $114K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $95K | – | – | – |
|
4
State Street
Boston,
Massachusetts
| $58K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $42K | +$53.5K | +41 | New |
|
6
Northern Trust
Chicago,
Illinois
| $22K | – | – | – |
|
|
7
Renaissance Technologies
New York
| $14K | -$56.1K | -43 | -75% |
|
|
8
UBS Group
Zurich,
Switzerland
| $13K | +$17K | +13 | New |
|
|
9
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $7K | +$1.3K | +1 | +17% |
|
|
PWS
10
Private Wealth Strategies
New Albany,
Ohio
| $5K | – | – | – |
|
|
SM
11
Sabby Management
Miami Beach,
Florida
| $5K | – | – | – |
|
|
PVH
12
Psagot Value Holdings
Tel Aviv,
Israel
| $4K | – | – | – |
|
13
BlackRock
New York
| $1K | – | – | – |
|
FEED Hedge Fund Activity: Q3 2022 in Review
13 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q3 2022, worth a combined $679K — down 25% from $906K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FEED positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $53.5K. The largest seller was Renaissance Technologies, cutting an estimated $56.1K.
- 13 institutional investors held ENvue Medical Inc (FEED) as of Q3 2022, up from 11 in Q2 2022.
- Funds reported $679K of ENvue Medical Inc stock for Q3 2022, down 25% quarter-over-quarter.
- 2 funds opened new ENvue Medical Inc positions in Q3 2022 and 0 closed out, a net change of +2 holders.
- The largest ENvue Medical Inc buyer in Q3 2022 was Susquehanna International Group, an estimated $53.5K added.
- The largest ENvue Medical Inc seller in Q3 2022 was Renaissance Technologies, an estimated $56.1K sold.
Based on aggregated 13F filings for Q3 2022.